STING1 and neoplasm: STING has become a promising candidate for tumor treatment, but it is down-regulated in various tumor types, such as gastric cancer, colorectal cancer, lung cancer, and colon carcinoma, resulting in weakened immunity and aggravated tumor growth [14,15].